Deutsche Bank analyst Dan Leonard raised his price target for Thermo Fisher to $300 from $275 saying the acquisition of Brammer Bio fills the gap in its contract services offering. The analyst believes Thermo Fisher can continue to exceed market growth rates "despite uniquely challenging comps." He says the acquisition supports his thesis and keeps a Buy rating on the shares.
Deutsche Bank raised the firm's price target on Thermo Fisher to $610 from $600 and keeps a Buy rating on the shares post the Q1 report. The analyst says a solid operational performance drove a strong start to 2024.
Barclays analyst Luke Sergott raised the firm's price target on Thermo Fisher to $615 from $590 and keeps an Equal Weight rating on the shares. The company reported a beat across the board, says the analyst, who sees the business stabilizing.
Check out this morning's top movers from around Wall Street, compiled by The Fly. UP AFTER EARNINGS... To see the rest of the story go to thefly.com. See Story Here